Lumira Ventures

Canada&s;s leading health care &a; life sciences venture capital firm with a 30-year reputation building companies across North America.

Business Model:

Revenue: $19M

Employees: 11-50

Rankings

Detailed Lumira Ventures Information

Geographic Data

Lumira Ventures headquarters map

Address: 141 Adelaide Street

City: Toronto

State: ontario

Zip: M5H 3L5

Country: CA

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$255M

Metrics

1,995,171Website Global Rank

10,464Website Monthly Traffic

Twitter Followers

Description

With a 30-year reputation as a leading North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meeting significant unmet needs and creating transformation impact in communities worldwide. Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
11/2013 enGene Venture Round 13.3M
5/2016 Opsens Post-IPO Equity 5M
2/2013 BAROnova Series C 27.3M
2/2018 Exact Imaging Series D -
12/2021 OncoMyx Therapeutics Series B 0
1/2019 enGene Venture Round -
10/2021 Deka Biosciences Series A 0
7/2015 BAROnova Venture Round -
9/2014 Forbius Venture Round -
9/2022 Damona Pharmaceuticals Seed Round 0
9/2017 Stellar Biotechnologies Post-IPO Equity 0
10/2018 Pediapharm Post-IPO Equity 47.6M
5/2017 Forbius Series B -
12/2019 Bright Angel Therapeutics Seed Round -
5/2016 Osteopathy Quebec Venture Round -
5/2017 Osteopathy Quebec Venture Round -
5/2011 U-Systems Venture Round 0
2/2021 Iterion Therapeutics Series B 17M
12/2020 Cyrano Therapeutics Series A 12.8M
5/2020 IMV Inc Post-IPO Equity 18M
1/2023 Cardiac Dimensions Series D 35M
12/2007 Cardiac Dimensions Series D 0
4/2018 Cardiac Dimensions Series B 39M
1/2015 enGene Series B 0
11/2014 OsteoQC Inc Seed Round -
11/2018 Gladius Pharmaceuticals Venture Round -
6/2015 Celtaxsys Series D 0
4/2019 Bardy Diagnostics Series B 35.5M
5/2020 IMV Post-IPO Equity 25.1M
12/2018 Exact Imaging Venture Round -
1/2018 Exact Imaging Venture Round -
1/2018 Celtaxsys Series E -
1/2017 Exact Imaging Series C 16.3M
6/2020 HistoSonics Series C 40M
11/2013 Argos Therapeutics Series E 0
4/2012 Argos Therapeutics Series D 0
9/2017 Engage Therapeutics Series A 23.6M
11/2017 KalGene Pharmaceuticals Series A -
5/2013 Vendorlink.ca Venture Round -
6/2018 KisoJi Biotechnology Series A -
9/2018 Osteopathy Quebec Venture Round -
11/2014 Osteopathy Quebec Seed Round -
12/2021 Specific Biologics Seed Round -
8/2021 Thryv Therapeutics Series A 0
4/2021 Antios Therapeutics Series B 0
2/2014 Aurinia Pharmaceuticals Post-IPO Equity 52M
10/2022 PIC Therapeutics Series A 35M
11/2015 Social Change Rewards Venture Round 2M
1/2018 KisoJi Biotechnology Venture Round -
2/2022 Congruence Therapeutics Series A 0
10/2008 Pathfinder Therapeutics Series A 0
11/2015 BAROnova Series D 36.5M
11/2015 First Aid Shot Therapy Series C 24M
4/2014 Cardiac Dimensions Series A 0
3/2021 XyloCor Therapeutics Series A 0
6/2022 X4 Pharmaceuticals Post-IPO Equity 0
3/2013 Corvia Medical Series C 10.7M
4/2019 Satsuma Pharmaceuticals Series B 0
2/2021 AmacaThera Series A 0
2/2015 G1 Therapeutics Series B 0
11/2021 Antios Therapeutics Series B 0
9/2013 Aurinia Pharmaceuticals Post-IPO Equity 5.8M
7/2016 Endotronix Series C 0
12/2022 HistoSonics Convertible Note 85M
5/2021 BioTheryX Series E 92M
3/2015 Vascular Pharmaceuticals Series A 9M
10/2019 AmacaThera Seed Round 2.7M
2/2021 Notch Therapeutics Series A 85M
10/2014 Cardiac Dimensions Series A 8.5M
10/2012 Thrasos Series C 35M
4/2012 Forbius Series A -
7/2014 Corvia Medical Series D 34M
4/2019 HistoSonics Series C 0
6/2015 Gladius Pharmaceuticals Series A 3.3M
3/2015 Thrasos Series D 21M
10/2016 KisoJi Biotechnology Series A -
3/2018 KalGene Pharmaceuticals Series A 1.3M
11/2018 Antios Therapeutics Series A 0
9/2017 Edesa Biotech Series A 7M
5/2016 G1 Therapeutics Series C 0
3/2015 Cardiac Dimensions Equity 15.2M
9/2018 Endotronix Series D 0
9/2020 Cardiac Dimensions Series C 17.5M
12/2021 Viron Series B 50M
4/2023 Antiva Biosciences Series E 0
6/2014 Spinal Kinetics Venture Round 34M
1/2016 Zymeworks Series A 0
11/2021 Antiva Biosciences Series D 0
6/2022 X4 Pharmaceuticals Post-IPO Equity 0
2/2022 Congruence Therapeutics Series A 0
12/2021 Specific Biologics Seed Round -
12/2021 OncoMyx Therapeutics Series B 0
12/2021 Viron Inc. Series B 0
11/2021 Antios Therapeutics Series B 0
11/2021 Antiva Biosciences Series D 0
10/2021 Deka Biosciences Series A 0
8/2021 Thryv Therapeutics Series A 0
5/2021 BioTheryX Series E 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research